PT-141 · two needle-free routesTroche or nasal spray, eight doses a month
About $13.63 a dose
Prescription PT-141 · two routes
Clinician-prescribed PT-141, troche or nasal spray. From $109 a month.
PT-141 acts on the melanocortin pathway in the brain. That is the pathway that drives desire, not the one that moves blood. It is a different target and a different kind of evening.
$54.50 your first month, then $109 monthly.
“It feels spontaneous again”
Two ways to take it
The molecule is the same in both. What changes is where it is absorbed, how far ahead you take it, and what it costs.
Take one when you want it
You want the cheapest way in and two strengths to choose from.
Use it 30 to 60 minutes ahead
You want the route with early human intranasal research behind it.
One price covers the online visit, the licensed provider review, the medication from a U.S. compounding pharmacy, and free delivery. The troche also comes in 2 mg at $119 a month.
Why people start
The older category is built around blood flow. Plenty of people do not have a blood-flow problem. They have a wanting problem, and it has its own pathway.
Blood-flow medicines assume the desire is already there and the plumbing is the problem. If the desire is the problem, they solve the wrong half. PT-141 goes at the receptor pathway that drives it.
Eight doses a month, taken when you want them. The troche goes in your mouth with no clock to watch. The spray goes in 30 to 60 minutes ahead of time.
You write it down instead. A licensed provider reads it, asks what they need to ask, and prescribes. Plain packaging arrives at your door.
Side by side
Strength, timing, package, and price. Pick a column and the button carries that route into your visit.
Swipe to compare both routes →
Decided
The troche is $54.50 for your first month and about $13.63 a dose at eight doses. One written visit, a licensed provider, and the jar arrives in plain packaging.
$54.50first month, then $109
Start with the trochePrefer the spray? 5 mL bottle · 30-day package, $99.50 your first month. Start with the nasal spray.
The pathway
Bremelanotide is a synthetic analogue of alpha-melanocyte-stimulating hormone and an agonist at the MC3R and MC4R melanocortin receptors. Those receptors sit on central pathways tied to sexual behaviour. That is a different address from the one PDE5 medicines write to.
Melanocortin receptors in the central nervous system, not smooth muscle in peripheral tissue.
As-needed, up to eight doses a month, on either route. Nothing to take on the days you do not want it.
A mini troche that dissolves in the mouth, or a metered nasal spray. No syringes on either route.
Verified Rebody customers
Reviews from Rebody customers on the PT-141 troche and the PT-141 nasal spray.
I almost canceled the appointment because this was not an easy subject for me to talk about. My Rebody doctor was kind, professional and made me comfortable from the first conversation. The PT-141 troches have made a real difference in my desire and in my relationship with my husband. Everything arrived discreetly, and customer service has been wonderful.
I almost did not write a review because this is such a private topic, but maybe it will help someone else. My desire had been gone for a long time and it was creating distance between my husband and me. My Rebody doctor treated me with kindness and zero judgment, and the PT-141 spray has made intimacy feel natural and spontaneous again. The change in our relationship has been incredible. I am deeply grateful for the care I received.
The PT-141 spray took a couple tries to get the timing right but once I did I noticed a real difference. I feel more interested and present instead of stuck in my head. The instructions were clear and my Rebody doctor answered my question without making it awkward.
From visit to doorstep
You write it down once. A licensed provider takes it from there and the pharmacy ships to your door.
Desire, medicines, blood pressure, heart history, and what you have already tried. No appointment and no waiting room.
A U.S.-licensed clinician reviews your history and decides the route and the strength that fit you.
A licensed U.S. compounding pharmacy prepares your PT-141 and ships it in plain packaging.
Message your care team about timing, strength, side effects, or refills. Pause or cancel whenever you want.
PT-141 questions
Routes, strengths, dose limits, and who prescribes. Pricing detail lives on the PT-141 pricing page.
PT-141 is bremelanotide, a synthetic analogue of alpha-melanocyte-stimulating hormone. It is an agonist at the MC3R and MC4R melanocortin receptors, which sit on the brain pathway involved in sexual desire. PDE5 medicines work further downstream on blood flow. PT-141 works on the wanting.
The troche is the lower price and comes in 1 mg and 2 mg, so a provider can start you low. The nasal spray is timed 30 to 60 minutes ahead and is the route with published early human intranasal research behind it. Both are needle-free and both allow up to eight doses a month.
No. The FDA-approved bremelanotide injection is indicated for premenopausal women with acquired, generalized hypoactive sexual desire disorder. Rebody's compounded troche and nasal spray are prescribed to men and women after a licensed provider reviews the visit. Early intranasal PT-141 research was published in both men and women.
Both routes are as-needed, up to eight doses a month. The troche is limited to one in 24 hours. Your prescription label carries the exact directions your provider writes for you.
Yes. Message your care team from the portal. A provider reviews the change and your plan and refill timing update from there.
Yes. A U.S.-licensed provider reviews your online visit and decides whether PT-141 is appropriate for you. A licensed U.S. compounding pharmacy fills and ships it.
Important safety information
Bremelanotide's approved label is contraindicated in uncontrolled high blood pressure and in known cardiovascular disease. Tell your provider your blood pressure, your heart history, every medicine and supplement you take, whether you take naltrexone, and whether you are pregnant or breastfeeding.
Nausea, flushing, and headache were the reactions most often reported in bremelanotide trials. The approved label also covers a temporary rise in blood pressure, a fall in heart rate, and darkening of skin in patches. Get urgent care for hives, swelling, trouble breathing, chest tightness, or fainting.
The FDA-approved bremelanotide product is Vyleesi, a 1.75 mg subcutaneous autoinjector for acquired, generalized hypoactive sexual desire disorder in premenopausal women. Rebody's troche and nasal spray are compounded prescription medications. They are a different product and they do not carry that approval or that indication.
Compounded medications are not FDA-approved or evaluated by the FDA for safety, efficacy, or quality. Prescription treatment requires a provider decision and is not available in every state.PT-141 at home
Two needle-free routes from $54.50 for your first month, with the visit, the provider review, and delivery included.
